Neuroendoscopy Devices Market Analysis Report By Surgery (Intraventricular, Transcranial, Transnasal), By Device Type (Rigid, Flexible), By Application, And Segment Forecasts, 2018 - 2025

Industry Insights

The global neuroendoscopy devices market size was valued at USD 102.5 million in 2016 and is expected to grow at a CAGR of 8.1% over the forecast period. Demand for neuroendoscopy is increasing due to the global rise in a number of brain tumor cases and the growing demand for minimally invasive surgical procedures.

These devices are majorly used during the treatment of diseases such as pituitary tumors, hydrocephalus, intraventricular hemorrhage & bleeding. As a result, constant rise in the incidence of pituitary tumors and intraventricular hemorrhage is driving the growth of the market.

Conventional surgical procedures of the brain such as craniotomy are complex and invasive and include a complete opening of the skull. These procedures possess a high risk of stroke or hemorrhage, blindness, deafness, and in some cases death. Minimally invasive procedures have a limited risk of developing above-mentioned conditions. Thus, neuroendoscopy being minimally invasive technique, demand for the same is constantly escalating.

Surgery Insights

Intraventricular segment accounted for the largest revenue share in 2016. B.Braun Medical Inc. and Medtronic are a few leading companies that offer intraventricular neuroendoscopy devices. Increasing cases of intraventricular hemorrhage and bleeding, and availability of technically advanced products are some of the key factors propelling the demand for these devices.

Transcranial segment is expected to grow at the fastest CAGR during the forecast period of 2017-2025. Increasing cases of pituitary gland tumors, hydrocephalus, and macroadenomas are anticipated to accelerate the growth of the segment.

Device Type Insights

Rigid neuroendoscopes are used for the treatment of diseases such as cystic lesions, hydrocephalus and intraventricular tumors. Thus, increasing in the prevalence of these diseases drives market growth. In addition, these devices are available in lighter and smaller versions. Consequently, such devices have higher demand, especially in the cases of interventricular surgeries.

Rigid neuroendoscopes accounts for the largest revenue share. The majority of the manufacturers relies on the rigid neuroendoscopes. Rigid neuroendoscopes are used for the treatment of diseases such as cystic lesions, hydrocephalus, and intraventricular tumors. According to Hydrocephalus Association U.S., 1 to 2 of every 1000 babies born, suffer from hydrocephalus. Thus, growing prevalence of these diseases drives the demand for rigid neuroendoscopes.  

Application Insights

Various initiatives undertaken by the government; institutions to support the adoption of neuroendoscopy and increasing research and development investment by the key players are some of the factors that are contributing to the market growth.

Hospitals dominate the overall application segment with the largest revenue share. Hospitals are preferring neuroendoscopy since they offer benefits such as minimal invasive procedure, precise access to the target site located in the interior parts of brain. In addition, hospitals register the largest number of neuroendoscopies in a year owing to the availability of advanced healthcare facilities in case of emergencies, highly skilled staff, and neurosurgeons. As a result, hospitals are the largest revenue generating centers.

Regional Insights

North America is the most developed market followed by Europe. Technological advancements in the healthcare sector and increasing incidences of the pituitary tumors are contributing to the growth of these markets. The U.S. is the largest market for neuroendoscopy across the world. Advantages of these procedures, such as minimal invasive technique offering faster recovery of patients, are among the key factors propelling their adoption in the country.

Asia Pacific market is expected to grow significantly owing to the availability of untapped growth opportunities in the region especially in, Japan, China, and India. Mandatory healthcare insurance, greater technological advancements, and increased healthcare expenditure are some of the growth drivers of the market in Asia Pacific.

Neuroendoscopy Devices Market Share Insights

Some of the key players in the sector are B. Braun Medical Inc., Karl Storz, Olympus Corporation, Zeiss International, Stryker, and Medtronic. Key players adopt strategies such as collaborations, mergers & acquisitions and enter into partnerships to strengthen their position in the sector. For instance, in July 2017, Stryker announced agreement to acquire Entellus Medical, Inc., a medical technology company that designs products for the minimally invasive treatment of various diseases related to ear, nose and throat. This acquisition will help Stryker to expand their revenue share.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the neuroendoscopy devices market report on the basis of surgery, device type, application and region:

• Surgery Type Outlook (Revenue, USD Million; 2014 - 2025)

  • Intraventricular

  • Transcranial

  • Transnasal

• Device Type Outlook (Revenue, USD Million; 2014 - 2025)

  • Rigid

  • Flexible

• Application Outlook (Revenue, USD Million; 2014 - 2025)

  • Hospitals

  • Medical Research Centers

• Regional Outlook (Revenue, USD Million; 2014 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa